In a research report published today, Roth Capital analyst Chris Lewis reiterated a Buy rating on Nanosphere (NASDAQ:NSPH) with a $1.50 price target, as NSPH …
In a research report issued today, Roth Capital analyst Chris Lewis maintained a Buy rating on Iradimed Corp (NASDAQ:IRMD) with a $14.00 price …
In a research note published yesterday, Roth Capital analyst Chris Lewis maintained a Buy rating on Nanosphere (NSPH) and cut his price target …
In a research report published yesterday, Roth Capital analyst Chris Lewis maintained a Buy rating on EnteroMedics Inc. (ETRM) with a $5 price …
In a research note released yesterday, Roth Capital analyst Chris Lewis reaffirmed a Buy rating on Nanosphere (NSPH) with a $3 price target …
In a research note published yesterday, Roth Capital analyst Chris Lewis reaffirmed a Buy rating on EnteroMedics Inc. (ETRM) with a $5 price …
In a research note issued today, Roth Capital analyst Chris Lewis reiterated a Buy rating on Align Technology (ALGN) with a $66 price target, following ALGN’s second quarter earnings results. Lewis …
Roth Capital analyst Chris Lewis was out yesterday with some bullish comments on Exact Sciences (EXAS), defining the stock’s price target at $20, and recommending buying the shares …
Nanosphere, Inc. (NSPH) announced this morning that it received FDA clearance for the bacterial portion of its enteric pathogen (EP) test.
In a research note issued today, Roth Capital analyst Chris Lewis reiterated a “Buy” rating on Align Technology (ALGN) and a price target of $66 following Danahers Corporation’s (DHR) …
